Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
On March 13, 2017, Apotex filed for leave to appeal the Federal Court of Appeal's (FCA) decision addressing validity and infringement of AstraZeneca's Canadian Patent No. 1,292,693 (the 693 Patent) (reported here) with the Supreme Court of Canada (SCC).
Torys LLP
Members of Torys' Food and Drug Regulatory team, Eileen McMahon, Teresa Reguly, Yolande Dufresne and Manpreet Singh...
Norton Rose Fulbright Canada LLP
Health Canada recently released for consultation the Draft Guidance Document – Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs.
Minden Gross LLP
Matt Maurer published an article on the Canadian government's commitment to legalize cannabis by June 1, 2017.
Miller Thomson LLP
Launched in June 2013, the Canadian Food Inspection Agency (CFIA)'s Food Labelling Modernization (FLM) initiative has been an ongoing project to overhaul food labelling in Canada.
Norton Rose Fulbright Canada LLP
Abbott Laboratories Limited, Takeda Pharmaceuticals Company Limited and Takeda Pharmaceuticals America Inc. (collectively, the Defendants) sought summary judgment of Apotex Inc.'s action for damages pursuant to section 8 of the Regulations.
Minden Gross LLP
Matt Maurer published his article on the signals the Health Minister has given regarding the legal age for cannabis consumption in Canada.
Devry Smith Frank LLP
Health Canada has temporarily shut down a drug supplier that provides a drug treatment for cancer patients. A hospital north of Toronto has had to delay treatments for patients...
Samis + Company
This decision reinforces the importance of considering the merit of each treatment and assessment plan disputed, despite a Section 38 deficiency.
Devry Smith Frank LLP
Over the past couple of weeks, Toronto Public Health has warned the public about an outbreak of mumps.
Norton Rose Fulbright Canada LLP
On February 20, 2017, Health Canada released the Draft Guidance Document – Drug Facts Table for Non-prescription Drugs for comment.
Norton Rose Fulbright Canada LLP
As previously reported here, Bill 92 proposed changes to a number of Quebec statutes. The bill has since passed and, with a few exceptions, is now in force.
Osler, Hoskin & Harcourt LLP
The Federal Court of Canada recently upheld Health Canada's denial of approval of a generic hormone replacement product (progesterone) submitted by Apotex
WeirFoulds LLP
Bill 87 (the "Bill"), which contains significant amendments to the Regulated Health Professions Act, 1991 ("RHPA"), passed first reading in the Ontario legislature in December 2016.
Gowling WLG
Today, most Canadian food importers and manufacturers don't consider licensing requirements and other prescriptive regulations with respect to how they conduct their business operations...
Howie, Sacks & Henry
When you visit a doctor and tell her you're in pain, she'll likely ask you to describe what you're feeling. Is it a dull ache? Is it a sharp stabbing sensation? Does the pain radiate through your body?
WeirFoulds LLP
On December 8, 2016, Bill 87, Protecting Patients Act, 2016, received first reading.
Minden Gross LLP
The Canadian government took another step this week towards permitting the use of roadside screening devices to detect drugs in impaired drivers.
McCague Borlack LLP
With the legalization of marijuana appearing more like a certainty than a possibility, legislators ought to be determining how best to address the increased societal risks...
Howie, Sacks & Henry
For many cancer patients who undergo chemotherapy, hair loss is an unfortunate but temporary side effect of their treatment. Chemotherapy drugs, including cytotoxic agents such as Taxotere...
Latest Video
Most Popular Recent Articles
Borden Ladner Gervais LLP
Legalizing cannabis for non-medical or "recreational" use is one of the most anticipated changes to Canadian society. In his election campaign, Prime Minister Justin Trudeau promised to legalize and regulate non-medical cannabis use.
Cassels Brock
Although the United States government's attitudes toward cannabis have eased in recent years, the election of President Donald Trump has generated renewed uncertainty....
Howie, Sacks & Henry
In this blog post, I explore some research into the long-term use of baby (talcum) powder and why Johnson & Johnson would prefer if you would focus on its pleasant smell...
McCarthy Tétrault LLP
In 2010, Mr. Skinner was involved in a motor vehicle accident while working, and subsequently developed a physical and mental disability.
Howie, Sacks & Henry
When you visit a doctor and tell her you're in pain, she'll likely ask you to describe what you're feeling. Is it a dull ache? Is it a sharp stabbing sensation? Does the pain radiate through your body?
McCague Borlack LLP
With the legalization of marijuana appearing more like a certainty than a possibility, legislators ought to be determining how best to address the increased societal risks...
Howie, Sacks & Henry
That hope was dashed for people who were given defective mesh products that ended up causing even more pain, complications and the need for additional surgeries.
Minden Gross LLP
The Canadian government took another step this week towards permitting the use of roadside screening devices to detect drugs in impaired drivers.
Norton Rose Fulbright Canada LLP
In its February 2017 newsletter, the PMPRB announced its intention to move patented generic drug price reviews to a complaint-based process, similar to the provisions for over-the-counter drug products...
Norton Rose Fulbright Canada LLP
The Court of Appeal held the trial judge did not err in her conclusion that it was not a proper case to apportion Apotex's profits.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with